Pleural Diseases: Clinical Trials

5 trials for Pleural Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 terminated. 5 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 15Terminated 5
Phase 22Terminated 2

Follow Pleural Diseases: new trials by email Literature Review of Pleural Diseases trials Research Report on Pleural Diseases

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Photodynamic Therapy to Amplify the Response to Immunotherapy in Patients With Non-small Cell Lung Cancer With Pleural Disease
Porfimer Sodium, Video-Assisted Thoracic Surgery, Photodynamic Therapy - Lung Non-Small Cell Carcinoma, Pleural Disorder
Phase 1TerminatedRoswell Park Cancer Institute52022-03-102026-02-04
A Study of Nivolumab and Intrapleural Talimogene Laherparepvec for Malignant Pleural Effusion
Talimogene laherparepvec (TVEC), Nivolumab - Malignant Pleural Effusion, Stage IV Metastatic Cancer
Phase 1 / Phase 2TerminatedUNC Lineberger Comprehensive Cancer Center12019-03-062021-04-20
Photo-induction as a Means to Improve Cisplatin Delivery to Pleural Malignancies
Cisplatin, liposomal, Verteporfin, Device for Intrapleural Visudyne-mediated Low-Dose Photodynamic Therapy with integrated in situ light dosimetry - Pleural Effusion, Malignant
Phase 1TerminatedCentre Hospitalier Universitaire Vaudois12016-01-012019-03-20
Intrapleural Bevacizumab After Pleural Drainage in the Context of Breast Cancer
Bevacizumab - Pleural Effusion, Malignant, Breast Cancer
Phase 1TerminatedInstitut Curie12014-12-092017-11-06
QUILT-2.013: First-Line Treatment for Extensive Stage Small Cell Lung Cancer
AMG 479, Etoposide, Placebo - Lung Cancer, Small Cell Lung Cancer
Phase 1 / Phase 2TerminatedNantCell, Inc.2132008-12-022024-08-23

Narrower conditions

Pleural Effusion, Malignant (4)  ·  Lung Neoplasms (2)  ·  Breast Neoplasms (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Neoplasm Metastasis (1)  ·  Neoplasms (1)  ·  Small Cell Lung Carcinoma (1)

Broader conditions

Neoplasms by Site (5)  ·  Respiratory Tract Diseases (5)  ·  Respiratory Tract Neoplasms (5)  ·  Thoracic Neoplasms (5)  ·  Neoplasms (4)  ·  Pleural Effusion (4)  ·  Pleural Neoplasms (4)  ·  Lung Diseases (3)  ·  Bronchial Neoplasms (2)  ·  Carcinoma, Bronchogenic (2)  ·  Breast Diseases (1)  ·  Lung Neoplasms (1)  ·  Neoplastic Processes (1)  ·  Pathologic Processes (1)

Interventions

Photochemotherapy (2)  ·  1-phenyl-3,3-dimethyltriazene (1)  ·  Bevacizumab (1)  ·  Carboplatin (1)  ·  Cisplatin (1)  ·  Dihematoporphyrin Ether (1)  ·  Etoposide (1)  ·  Nivolumab (1)  ·  SPI-77, liposomal (1)  ·  Thoracic Surgery, Video-Assisted (1)  ·  Trioxsalen (1)  ·  Verteporfin (1)  ·  ganitumab (1)  ·  lipoplatin (1)  ·  rilotumumab (1)

Sponsors

Centre Hospitalier Universitaire Vaudois (1)  ·  Institut Curie (1)  ·  NantCell, Inc. (1)  ·  Roswell Park Cancer Institute (1)  ·  UNC Lineberger Comprehensive Cancer Center (1)

Countries

United States (2)  ·  France (1)  ·  Switzerland (1)

Top investigators

Hans-Beat Ris, MD, Prof. (1)  ·  Jared Weiss, MD (1)  ·  Maya Gutierrez, MD (1)

NIH funding

2014 (1)